Sight Sciences, Inc. (SGHT)
Nasdaq: SGHT · Surgical & Medical Instruments & Apparatus · Menlo Park, CA · filing with the SEC since 2011
Who owns Sight Sciences, Inc.
As filed with the SECHolders of 5% or more
3
Staffan Encrantz holds 13.1% of Common Stock, par value $0.001, as its SCHEDULE 13D/A filed Mar 13, 2025 says.
Directors and officers
14
report now, of 22 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Staffan Encrantz
SCHEDULE 13D/A · filed Mar 13, 2025 · Common Stock, par value $0.001
Long Focus Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock · 5% in Jan 23, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Jan 21, 2026 · Common Stock
Kck Ltd.
SCHEDULE 13G/A · filed Apr 8, 2026 · Common Stock · reported falling below 5%, from 7% in Feb 4, 2026
UBS Group AG
SCHEDULE 13G/A · filed Aug 8, 2024 · Common Stock, par value $0.001 per share · reported falling below 5%
What SGHT reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 13, 2024.
Insider tradesForm 4
39sales
2purchases
26sales on a scheduled plan
6people selling
$2.9Msold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Oct 5, 2025 to Oct 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 31 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Badawi Paul | President and CEO | 6 | $1.0M | 4 | 0 | $0 |
| Bauerlein Alison | Chief Operating Officer | 6 | $700,000 | 4 | 0 | $0 |
| Hayden Jeremy B. | Chief Legal Officer | 7 | $600,000 | 7 | 0 | $0 |
| Rodberg James | Chief Financial Officer | 7 | $200,000 | 4 | 0 | $0 |
| Badawi David | Chief Technology Officer | 7 | $200,000 | 4 | 0 | $0 |
| Taylor Brenton | EVP, Operations & R&D | 6 | $200,000 | 3 | 0 | $0 |
| Encrantz Staffan | director | 0 | $0 | 0 | 2 | $200,000 |